Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 4, 2011, Pages 867-874

  Effenberger Neidnicht, Katharina ^a   Schobert, Rainer ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Anti tumour agents; Apoptosis; Conjugates; Doxorubicin; Multi drug resistance; Thymoquinone

Indexed keywords

CASPASE 3; DOXORUBICIN; REACTIVE OXYGEN METABOLITE; THYMOQUINONE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL STRAIN HL 60; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MIXTURE; DRUG POTENTIATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BENZOQUINONES; CELL LINE, TUMOR; DNA FRAGMENTATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 79954440155     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1386-x     Document Type: Article

References (31)

1. GM Cragg PG Grothaus DJ Newman 2009 Impact of natural products on developing new anti-cancer agents Chem Rev 109 3012 3043 19422222 10.1021/cr900019j 1:CAS:528:DC%2BD1MXlsFCns7Y%3D
2. MA Colucci CJ Moody GD Couch 2008 Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential Org Biomol Chem 6 637 656 18264564 10.1039/b715270a 1:CAS:528:DC%2BD1cXhs1yksb4%3D (Pubitemid 351972602)
3. JL Bolton MA Trush TM Penning G Dryhurst TJ Monks 2000 Role of quinones in toxicology Chem Res Toxicol 13 135 160 10725110 10.1021/tx9902082 1:CAS:528:DC%2BD3cXht1aitr4%3D (Pubitemid 30169958)
4. Robert J (1998) Anthracyclines. In: Grochow LB, Ames MM (eds) A clinician′s guide to chemotherapy. pharmacokinetic and pharmacodynamics, Williams & Wilkins, Baltimore, pp 93-173
5. OA Badary AM Gamal El-Din 2001 Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis Cancer Detect Prev 25 362 368 11531013 1:CAS:528:DC%2BD3MXmvV2ksrY%3D
6. H Gali-Muhtasib A Roessner R Schneider-Stock 2006 Thymoquinone: A promising anti-cancer drug from natural sources Int J Biochem Cell Biol 38 1249 1253 16314136 10.1016/j.biocel.2005.10.009 1:CAS:528:DC%2BD28XksVGgsro%3D
7. H Gali-Muhtasib M Ocker D Kuester S Krueger Z El-Hajj A Diestel M Evert N El-Najjar B Peters A Jurjus A Roessner R Schneider-Stock 2008 Thymoquinone reduces mouse colon tumour cell invasion and inhibits tumour growth in murine colon cancer models J Cell Mol Med 12 330 342 18366456 10.1111/j.1582-4934.2007. 00095.x (Pubitemid 351430474)
8. H Gali-Muhtasib M Diab-Assaf C Boltze J Al-Hmaira R Hartig A Roessner R Schneider-Stock 2004 Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via p53-dependent mechanism Int J Oncol 25 857 866 15375533 1:CAS:528:DC%2BD2cXovFWlurY%3D
9. MA El-Mahdy Q Zhu QE Wang G Wani AA Wani 2005 Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells Int J Cancer 117 409 417 15906362 10.1002/ijc.21205 1:CAS:528:DC%2BD2MXhtFant7rF (Pubitemid 41429564)
10. S Breyer K Effenberger R Schobert 2009 Effects of thymoquinone-fatty acid conjugates on cancer cells Chem Med Chem 4 761 768 19322799 1:CAS:528:DC%2BD1MXls1Kgt7o%3D
11. K Effenberger S Breyer R Schobert 2010 Terpene conjugates of the nigella sativa seed oil constituent thymoquinone with enhanced efficacy in cancer cells Chem Biodiv 7 129 139 10.1002/cbdv.200900328 1:CAS:528:DC%2BC3cXhtVKgsrw%3D
12. K Effenberger S Breyer R Schobert 2010 Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones Eur J Med Chem 45 1947 1954 20133021 10.1016/j.ejmech.2010.01.037 1:CAS:528: DC%2BC3cXjs12qsbk%3D
13. OA Al-Shabanah OA Badary MN Nagi NM Al-Gharably AC Al-Rikabi AM Al-Bekairi 1998 Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity J Exp Clin Cancer Res 17 193 198 9700580 1:CAS:528:DyaK1cXltFGjtbc%3D (Pubitemid 28335578)
14. MN Nagi MA Mansour 2000 Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection Pharmacol Res 41 283 289 10675279 10.1006/phrs.1999.0585 1:CAS:528: DC%2BD3cXhtFWjs78%3D (Pubitemid 30663132)
15. OA Badary OA Al-Shabanah MN Nagi AC Al-Rikabi MM Elmazar 1999 Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone Eur J Cancer Prev 8 435 440 10548399 10.1097/00008469-199910000-00009 1:STN:280:DC%2BD3c%2FhsVCgtw%3D%3D (Pubitemid 30048073)
16. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Meth 65 55 63 10.1016/0022-1759(83)90303-4 1:STN:280:DyaL2c%2FovFSmtw%3D%3D (Pubitemid 14203433)
17. WC Earnshaw LM Martins SC Kaufmann 1999 Mammalian caspases: structure, activation, substrates, and functions during apoptosis Annu Rev Biochem 68 383 424 10872455 10.1146/annurev.biochem.68.1.383 1:CAS:528:DyaK1MXlvFajsb0%3D (Pubitemid 29449198)
18. A Bas G Forsberg S Hammarström ML Hammarström 2004 Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate- dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T-lymphocytes Scand J Immunol 59 560 573 10.1111/j.0300-9475.2004.01440.x (Pubitemid 38789226)
19. S Desagher A Osen-Sand A Nichols R Eskes S Montessuit S Lauper K Maundrell B Antonsson JC Martinou 1999 Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis J Cell Biol 144 891 901 10085289 10.1083/jcb.144.5.891 1:CAS:528:DyaK1MXhs1yqtbY%3D (Pubitemid 29238966)
20. GAW Rook J Steele S Umar HM Dockrell 1985 A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for the activation of human macrophages by gamma interferon J Immunol Methods 82 161 167 3928762 10.1016/0022-1759(85)90235-2 1:CAS:528:DyaL2MXltl2rtLk%3D (Pubitemid 16247531)
21. TC Chou P Talalay 1981 Generalized equations for the analysis of inhibitors of Michaelis-Menten and higher order kinetic systems with two or more mutually exclusive and non-exclusive inhibitors Eur J Biochem 115 207 216 7227366 10.1111/j.1432-1033.1981.tb06218.x 1:CAS:528:DyaL3MXhtlCqsbk%3D
22. TC Chou P Talalay 1984 Quantitative analysis of dose effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzymol Regul 22 27 55 10.1016/0065-2571(84)90007-4 1:CAS:528:DyaL2cXktlaksLk%3D
23. S Wang EA Konorev S Kotamraju J Joseph S Kalivendi B Kalyanarama 2004 Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms J Biol Chem 279 25535 25543 15054096 10.1074/jbc.M400944200 1:CAS:528:DC%2BD2cXksFygsbc%3D (Pubitemid 38756813)
24. H Mizutani S Tada-Oikawa Y Hiraku M Kojima S Kawanishi 2005 Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide Life Sci 76 1439 1453 15680309 10.1016/j.lfs.2004.05.040 1:CAS:528: DC%2BD2MXntVSlsQ%3D%3D (Pubitemid 40164773)
25. DA Gewirtz 1999 A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochem Pharmacol 55 727 741 10.1016/S0006-2952(98)00307-4 (Pubitemid 29094544)
26. G Minotti P Menna E Salvatorelli G Cairo L Gianni 2004 Anthracyclines: molecular advances and pharmacologic developments in anti-tumour activity and cardiotoxicity Pharmacol Rev 56 185 229 15169927 10.1124/pr.56.2.6 1:CAS:528:DC%2BD2cXltlKgtb0%3D (Pubitemid 38720829)
27. N El-Najjar M Chatila H Moukadem H Vuorela M Ocker M Gandesiri R Schneider-Stock H Gala-Muhtasib 2010 Reactive oxygen species mediated thymoquinone-induced apoptosis and activate ERK and JNK signalling Apoptosis 15 183 195 19882352 10.1007/s10495-009-0421-z 1:CAS:528:DC%2BC3cXhtlSjsrg%3D
28. OA Badary RA Taha AMG El-Din MH Abdel-Wahab 2003 Thymoquinone is a potent superoxide anion scavenger Drug Chem Toxicol 26 87 98 12816394 10.1081/DCT-120020404 1:CAS:528:DC%2BD3sXkt1Ohurc%3D (Pubitemid 36597385)
29. L Benimetskaya JC Lai A Khvorova S Wu E Hua P Miller LM Zhang CA Stein 2004 Relative bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells Clin Cancer Res 10 8371 8379 15623615 10.1158/1078-0432. CCR-04-1294 1:CAS:528:DC%2BD2cXhtFGjs7zN (Pubitemid 40053399)
30. I Budihardjo H Oliver M Lutter X Luo X Wang 1999 Biochemical pathways of caspase activation during apoptosis Annu Rev Cell Dev Biol 15 269 290 10611963 10.1146/annurev.cellbio.15.1.269 1:CAS:528:DC%2BD3cXhtVSnuro%3D (Pubitemid 32250377)
31. E Bossy-Wetzel DD Newmeyer DR Green 1998 Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independent of mitochondrial transmembrane depolarization EMBO J 17 37 49 9427739 10.1093/emboj/17.1.37 1:CAS:528:DyaK1cXnvVyjsg%3D%3D (Pubitemid 28041046)